The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•12 February 2026•

1 min read

PMGC Holdings Inc Expands Animal Health Reach with Global License Deal

Donald Trump in a suit stands before the White House. Lab equipment, molecular models, and a signed "BIOTECH GROWTH INITIATIVE" executive order are in the foreground. Green glowing lines, a growth cha

PMGC Holdings Inc has announced a definitive license agreement for the commercialization of two key animal health products, EL-22 and EL-32. Under the terms, NorthStrive granted Modulant, a subsidiary, exclusive global rights, excluding Korea, for non-human animal health applications. Modulant will assume full responsibility for the development, manufacturing, and commercialization of these products. This strategic collaboration aims to significantly improve animal muscle health and feed efficiency. The agreement also includes shared ownership of any new intellectual property generated, fostering further innovation. This expansion of PMGC Holdings Inc's product portfolio and market reach in the animal health sector is anticipated to drive increased revenue and market share.